Last quarter (Q4 2023), Chemed's total revenue was $585.91M, an increase of 7.18% from the same quarter last year. In Q4, Chemed's net income was $90.05M. See Chemed’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 2.26B	$ 2.26B	$ 2.13B	$ 2.14B	$ 2.08B	$ 1.94B
Cost of Revenue	$ 1.47B	$ 1.47B	$ 1.37B	$ -1.37B	$ 1.38B	$ 1.32B
Gross Profit	$ 798.82M	$ 798.82M	$ 765.09M	$ 769.80M	$ 701.39M	$ 617.43M
Operating Expense	$ 458.25M	$ 458.25M	$ -417.90M	$ 426.76M	$ 306.58M	$ 350.92M
Operating Income	$ 340.57M	$ 340.57M	$ 347.19M	$ 343.04M	$ 394.81M	$ 266.51M
Net Non Operating Interest Income Expense	$ -3.21M	$ -3.11M	$ -4.23M	$ 7.28M	$ -1.60M	$ -4.02M
Other Income Expense	$ -332.11M	$ -12.91M	$ 13.28M	$ -457.00K	$ 2.78M	$ -881.00K
Pretax Income	$ 350.37M	$ 350.37M	$ 329.68M	$ 350.31M	$ 395.99M	$ 261.61M
Tax Provision	$ 77.86M	$ 77.86M	$ 80.06M	$ 81.76M	$ 76.52M	$ 41.69M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 272.51M	$ 272.51M	$ 249.62M	$ 268.55M	$ 319.47M	$ 219.92M
Basic EPS	-	-	-	-	$ 20.02	$ 13.77
Diluted EPS	-	-	-	-	$ 19.48	$ 13.31
Basic Average Shares	-	-	-	-	$ 15.96M	$ 15.97M
Diluted Average Shares	-	-	-	-	$ 16.40M	$ 16.53M
Dividend Per Share	-	-	-	-	$ 1.32	$ 1.24
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	$ 18.08	$ 13.95
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.92B	$ 1.92B	$ 1.79B	$ -942.69M	$ 1.68B	$ 1.67B
Net Income From Continuing And Discontinued Operation	$ 272.51M	$ 272.51M	$ 249.62M	$ 268.55M	$ 319.47M	$ 219.92M
Normalized Income	$ 163.83M	$ 220.05M	$ 204.08M	-	$ 323.61M	$ 227.60M
Interest Expense	-	-	-	-	$ 2.35M	$ 4.54M
EBIT	$ 350.83M	$ 350.83M	$ 330.56M	$ 350.78M	$ 398.35M	$ 266.14M
EBITDA	$ 412.27M	$ 412.27M	$ 390.07M	$ 410.14M	$ 454.93M	$ 311.35M

Currency in USD

Chemed Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing